---

Advertising Information | FAQs | About Us | Contact Us | Privacy Policy

---

The Changing Policy Landscape

Prepare Now for the Coming FDA and Pharmaceutical Marketing Reforms

"The two traditional means by which pharmaceutical marketers have relied on for many, many years to encourage the uptake of new pharmaceutical products -- direct-to-consumer (DTC) advertising and physician marketing -- are about to change," warned Mark S. Senak, J.D., SVP, Fleishman-Hillard and author of Eye On FDA Blog, in a presentation at the recent DTC in the Era of Consumer Choice conference. Senak summarized all the possibly policy changes coming down the pike that will specifically impart pharmaceutical marketing. He also suggests what the industry should be doing to meet these challenges. This article is summarizes Senak's presentation, which he later expanded upon in a YouTube video. Topic headings include: Changes Ahead for DTC Marketing Adverse Event Reporting Info in TV Ads Drug Safety Pricing Pressure Changing Communications Landscape Suggestions for Action Overcoming Regulatory Roadblocks

Order and pay for this reprint now using your credit card...

ONLY $6.95
Download PDF file immediately after paying:

PMN710-01
Issue: Vol. 7, No. 10: December 2008
Word Count: 2777

Find other articles in related Topic Areas:

• Direct-to-Consumer (DTC) Advertising & Marketing
• Physician Marketing & Promotion
• Regulatory Compliance
• Strategic Marketing & Planning